Celltrion Will Attend 2026 Biotech Exhibition in Milan
The company plans to showcase its drug pipeline and CDMO services at the event from October 6 to 8, 2026.
Updated on Sept. 29, 2026 in Biotech
Live Poll
Do you believe attending international industry trade shows is an effective way for companies to grow?
Celltrion will host a solo booth at the 2026 World Pharmaceutical and Biotechnology Exhibition, which takes place in Milan, Italy, from October 6 to 8, 2026. This appearance marks the company's fifth consecutive year hosting an independent presence at the global industry gathering.
Why it matters
Celltrion aims to leverage the exhibition to expand its international drug pipeline through new collaborations. The company also intends to use the event to secure potential clients for its contract development and manufacturing organization services.
Celltrion will be represented by a team including 6 experts at the booth. The firm is actively researching treatments for anticancer, obesity, and metabolic diseases.
The players
Celltrion
Celltrion is a major biopharmaceutical company focused on the development and production of biosimilars and new drug treatments.
The details
Corporate representatives will host on-site programs designed to promote the company's technological capabilities and value. During the exhibition, staff plan to meet with industry experts to explore potential partnerships for developing their new drug pipeline.
Timeline
Celltrion began operating a solo booth at the exhibition in 2022.
The company announced its upcoming participation on September 29, 2026.
The World Pharmaceutical and Biotechnology Exhibition will occur from October 6 to 8, 2026.
The Tech Race
Participation in global industry events has become a critical strategy for biotech firms looking to secure manufacturing contracts and collaborative R&D opportunities. Celltrion's continued solo presence highlights its shift toward scaling its own pipeline while competing for international CDMO market share.
While the exhibition targets professional collaboration, these industry moves ultimately shape the future availability of anticancer and metabolic disease treatments. Success in these partnerships can lead to faster development timelines for next-generation medications.
The takeaway
Companies in the pharmaceutical sector are increasingly prioritizing large-scale industry exhibitions to solidify their global manufacturing footprints. Strategic networking at these events remains a vital component for firms seeking to transition from local research to international production scale.
Further reading
Learn more about the latest industry developments in the Biotech section.
Live Poll
Do you believe attending international industry trade shows is an effective way for companies to grow?
